• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2015年北欧地区痛风负担:全球疾病负担研究2015的结果

Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015.

作者信息

Kiadaliri A A, Uhlig T, Englund M

机构信息

a Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit , Lund University , Lund , Sweden.

b Department of Rheumatology, National Advisory Unit for Rehabilitation in Rheumatology , Diakonhjemmet Hospital , Oslo , Norway.

出版信息

Scand J Rheumatol. 2018 Sep;47(5):410-417. doi: 10.1080/03009742.2017.1405461. Epub 2018 Jan 29.

DOI:10.1080/03009742.2017.1405461
PMID:29376465
Abstract

OBJECTIVE

To explore the burden of gout in the Nordic region, with a population around 27 million in 2015 distributed across six countries.

METHOD

We used the findings of the 2015 Global Burden of Diseases study to report prevalence and disability associated with gout in the Nordic region.

RESULTS

From 1990 to 2015, the number of prevalent gout cases rose by 30% to 252 967 [95% uncertainty interval (UI) 223 478‒287 288] in the Nordic region. In 2015, gout contributed to 7982 (95% UI 5431‒10 800) years lived with disability (YLDs) in the region, an increase of 29% (95% UI 24‒35%) from 1990. While the crude YLD rate of gout increased by 12.9% (95% UI 7.8‒18.1%) between 1990 and 2015, the age-standardized YLD rate remained stable. Gout was ranked as the 63rd leading cause of total YLDs in the region in 2015, with the highest rank in men aged 55-59 years (38th leading cause of YLDs). The corresponding rank at the global level was 94. Of 195 countries studied, four Nordic countries [Greenland (2nd), Iceland (12th), Finland (14th), and Sweden (15th)] were among the top 15 countries with the highest age-standardized YLD rate of gout.

CONCLUSION

The burden of gout is rising in the Nordic region. Gout's contribution to the total burden of diseases in the region is more significant than the global average. Expected increases in gout burden owing to population growth and ageing call for stronger preventive and therapeutic strategies for gout management in Nordic countries.

摘要

目的

探讨北欧地区痛风的负担情况,2015年该地区人口约2700万,分布在六个国家。

方法

我们利用2015年全球疾病负担研究的结果报告北欧地区痛风的患病率和相关残疾情况。

结果

1990年至2015年,北欧地区痛风的患病人数增加了30%,达到252967例[95%不确定区间(UI)223478 - 287288]。2015年,痛风导致该地区7982例(95% UI 5431 - 10800)伤残调整生命年(YLDs),较1990年增加了29%(95% UI 24 - 35%)。虽然痛风的粗YLD率在1990年至2015年间增加了12.9%(95% UI 7.8 - 18.1%),但年龄标准化YLD率保持稳定。2015年,痛风在该地区YLDs总数的主要病因中排名第63位,在55 - 59岁男性中排名最高(YLDs的第38大病因)。在全球层面的相应排名为第94位。在研究的195个国家中,四个北欧国家[格陵兰(第2位)、冰岛(第12位)、芬兰(第14位)和瑞典(第15位)]位列痛风年龄标准化YLD率最高的前15个国家。

结论

北欧地区痛风负担正在上升。痛风对该地区疾病总负担的贡献比全球平均水平更为显著。由于人口增长和老龄化导致痛风负担预计增加一事,要求北欧国家采取更强有力的痛风管理预防和治疗策略。

相似文献

1
Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015.1990 - 2015年北欧地区痛风负担:全球疾病负担研究2015的结果
Scand J Rheumatol. 2018 Sep;47(5):410-417. doi: 10.1080/03009742.2017.1405461. Epub 2018 Jan 29.
2
Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.1990 - 2015年北欧地区类风湿关节炎负担:基于2015年全球疾病负担研究的比较分析
Scand J Rheumatol. 2018 Mar;47(2):1-101. doi: 10.1080/03009742.2017.1314002. Epub 2017 Aug 2.
3
Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990-2017: A Systematic Analysis of the Global Burden of Disease Study 2017.1990-2017 年全球 195 个国家和地区痛风的患病率、发病率及伤残调整寿命年(因痛风导致的失能)及其归因危险因素分析:基于 2017 年全球疾病负担研究的系统分析
Arthritis Rheumatol. 2020 Nov;72(11):1916-1927. doi: 10.1002/art.41404. Epub 2020 Sep 10.
4
High and rising burden of hip and knee osteoarthritis in the Nordic region, 1990-2015.北欧地区髋和膝关节骨关节炎的负担日益加重,1990-2015 年。
Acta Orthop. 2018 Apr;89(2):177-183. doi: 10.1080/17453674.2017.1404791. Epub 2017 Nov 21.
5
Alcohol-attributed disease burden in four Nordic countries: a comparison using the Global Burden of Disease, Injuries and Risk Factors 2013 study.四个北欧国家的酒精所致疾病负担:基于《2013年全球疾病、伤害及风险因素负担研究》的比较
Addiction. 2016 Oct;111(10):1806-13. doi: 10.1111/add.13430. Epub 2016 Jun 6.
6
The global burden of gout: estimates from the Global Burden of Disease 2010 study.全球痛风负担:来自 2010 年全球疾病负担研究的估计。
Ann Rheum Dis. 2014 Aug;73(8):1470-6. doi: 10.1136/annrheumdis-2013-204647. Epub 2014 Mar 3.
7
Secular Trends in Musculoskeletal Rehabilitation Needs in 191 Countries and Territories From 1990 to 2019.1990 年至 2019 年 191 个国家和地区肌肉骨骼康复需求的长期趋势。
JAMA Netw Open. 2022 Jan 4;5(1):e2144198. doi: 10.1001/jamanetworkopen.2021.44198.
8
The temporal trends of prevalence and years lived with disability of anaemia in China, Japan, and South Korea, from 1990 to 2021: Results from the Global Burden of Disease Study 2021.中国、日本和韩国 1990 年至 2021 年贫血患病率和伤残调整寿命年的时间趋势:2021 年全球疾病负担研究结果。
J Glob Health. 2024 May 24;14:04073. doi: 10.7189/jogh.14.04073.
9
Health and Economic Outcomes Associated With Musculoskeletal Disorders Attributable to High Body Mass Index in 192 Countries and Territories in 2019.2019年192个国家和地区中与高体重指数所致肌肉骨骼疾病相关的健康和经济后果
JAMA Netw Open. 2023 Jan 3;6(1):e2250674. doi: 10.1001/jamanetworkopen.2022.50674.
10
The prevalence and years lived with disability caused by low back pain in China, 1990 to 2016: findings from the global burden of disease study 2016.中国 1990 年至 2016 年腰痛导致的患病率和残疾年数:2016 年全球疾病负担研究的结果。
Pain. 2019 Jan;160(1):237-245. doi: 10.1097/j.pain.0000000000001396.

引用本文的文献

1
Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study.生活方式因素可预测痛风结局:来自 NOR-Gout 纵向 2 年达标治疗研究的结果。
RMD Open. 2023 Dec 1;9(4):e003600. doi: 10.1136/rmdopen-2023-003600.
2
Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study.痛风患者工作生产力的病程和预测因素 - 来自 NOR-Gout 纵向 2 年达标治疗研究的结果。
Rheumatology (Oxford). 2023 Dec 1;62(12):3886-3892. doi: 10.1093/rheumatology/kead124.
3
Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case-Control Study.
格陵兰和丹麦接受降尿酸药物治疗的患者患病率:一项横断面病例对照研究。
Int J Environ Res Public Health. 2022 Jun 13;19(12):7247. doi: 10.3390/ijerph19127247.
4
Gout and Hospital Admission for Ambulatory Care-Sensitive Conditions: Risks and Trajectories.痛风与需门诊治疗的慢性病住院:风险和轨迹。
J Rheumatol. 2022 Jul;49(7):731-739. doi: 10.3899/jrheum.220038. Epub 2022 Apr 15.
5
Cause-Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study.美国退伍军人事务部痛风患者的病因特异性死亡率:一项匹配队列研究。
Arthritis Care Res (Hoboken). 2023 Apr;75(4):808-816. doi: 10.1002/acr.24881. Epub 2022 Nov 11.
6
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target.真实世界观察性达标与强化治疗 NOR-Gout 研究的 12 个月结果:尿酸达标水平的实现情况及其达标预测因素。
RMD Open. 2021 Mar;7(1). doi: 10.1136/rmdopen-2021-001628.
7
Educational inequalities in all-cause and cause-specific mortality among people with gout: a register-based matched cohort study in southern Sweden.痛风患者全因死亡率和死因特异性死亡率的教育不平等:瑞典南部基于登记的匹配队列研究。
Int J Equity Health. 2019 Oct 28;18(1):164. doi: 10.1186/s12939-019-1076-1.
8
L. Extract Suppresses Experimental Gout by Inhibiting the NF-κB and NLRP3 Signaling Pathways.L. 提取物通过抑制 NF-κB 和 NLRP3 信号通路抑制实验性痛风。
Int J Mol Sci. 2019 Oct 4;20(19):4921. doi: 10.3390/ijms20194921.
9
Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression.罗米地辛通过上调细胞因子信号转导抑制因子 1 的表达抑制单钠尿酸盐晶体诱导的细胞因子产生。
Arthritis Res Ther. 2019 Feb 6;21(1):50. doi: 10.1186/s13075-019-1834-x.
10
Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015.1998-2015 年瑞典类风湿关节炎和痛风住院治疗的时间趋势和地域差异。
Clin Rheumatol. 2018 Mar;37(3):825-830. doi: 10.1007/s10067-018-3983-8. Epub 2018 Jan 22.